According to internal sources who requested anonymity, multiple global pharmaceutical clients are closely monitoring Samsung Biologics’ ongoing labor-management conflict and have explicitly expressed ...
Yonhap News Agency on MSN3d
Samsung Biologics' new plant set to be completed next month: CEOThe chief of Samsung Biologics Co., the biotech arm of South Korea's Samsung Group, said Friday its new biomedicine ...
Samsung Biologics CEO John Lim reveals 5th factory completion plans for next month Joonrim Samba expands global presence with ...
Samsung is backing Alzheimer’s disease blood test developer C2N Diagnostics, with $10 million to help scale up its commercial ...
Samsung Biologics is planning more than 50 meetings with global big pharmaceutical companies at the upcoming DCAT Week 2025 ...
Medical Device Network on MSN2d
C2N Diagnostics lands $10m cash injection from SamsungC2N Diagnostics has received a $10m strategic investment out of Samsung’s life science investment fund. The US company said ...
South Korean stocks finished markedly higher Monday led by gains of top-cap Samsung Electronics and other tech shares tracking their Wall Street peers despite lingering concerns about US President ...
Excluding the year 2020 when the event was not held due to COVID-19, Samsung Biologics has participated in DCAT Week for ten ...
Samsung Biologics, the biotech arm of Samsung Group, said Monday that it will participate in DCAT Week 2025, taking place March 17-20 in New York, as part of its efforts to expand its global business ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback